[go: up one dir, main page]

EP1027049A4 - Formulation intranasale contenant de la scopolamine et methode de traitement du mal des transports - Google Patents

Formulation intranasale contenant de la scopolamine et methode de traitement du mal des transports

Info

Publication number
EP1027049A4
EP1027049A4 EP98946945A EP98946945A EP1027049A4 EP 1027049 A4 EP1027049 A4 EP 1027049A4 EP 98946945 A EP98946945 A EP 98946945A EP 98946945 A EP98946945 A EP 98946945A EP 1027049 A4 EP1027049 A4 EP 1027049A4
Authority
EP
European Patent Office
Prior art keywords
disease
formulation containing
intranasal formulation
containing scopolamine
travel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP98946945A
Other languages
German (de)
English (en)
Other versions
EP1027049A1 (fr
Inventor
Raja G Achari
Charanjit R Behl
Prafulla K Chowhan
Meireles C Jorge De
Ramneik Dua
Vincent D Romeo
Anthony P Sileno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
MDRNA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDRNA Inc filed Critical MDRNA Inc
Publication of EP1027049A1 publication Critical patent/EP1027049A1/fr
Publication of EP1027049A4 publication Critical patent/EP1027049A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP98946945A 1997-09-11 1998-09-11 Formulation intranasale contenant de la scopolamine et methode de traitement du mal des transports Ceased EP1027049A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5865197P 1997-09-11 1997-09-11
US58651P 1997-09-11
PCT/US1998/018953 WO1999012544A1 (fr) 1997-09-11 1998-09-11 Formulation intranasale contenant de la scopolamine et methode de traitement du mal des transports

Publications (2)

Publication Number Publication Date
EP1027049A1 EP1027049A1 (fr) 2000-08-16
EP1027049A4 true EP1027049A4 (fr) 2001-09-05

Family

ID=22018094

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98946945A Ceased EP1027049A4 (fr) 1997-09-11 1998-09-11 Formulation intranasale contenant de la scopolamine et methode de traitement du mal des transports

Country Status (5)

Country Link
EP (1) EP1027049A4 (fr)
JP (1) JP2002516815A (fr)
AU (1) AU742878B2 (fr)
CA (1) CA2303132C (fr)
WO (1) WO1999012544A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
JP5391691B2 (ja) 2006-03-31 2014-01-15 和光純薬工業株式会社 ピラゾール系シアニン色素
KR101444712B1 (ko) 2007-01-31 2014-09-26 와코 쥰야꾸 고교 가부시키가이샤 게놈 ｄｎａ 단편의 증폭 또는 결실의 검출방법
US20250057853A1 (en) * 2023-08-04 2025-02-20 Repurposed Therapeutics, Inc. Compositions and methods for the treatment of motion sickness and emesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131315A2 (fr) * 1983-05-13 1985-01-16 ISTITUTO DE ANGELI S.p.A. Préparations nasales contenant des sels d'ammonium quaternaires anticholinergiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7765615B2 (en) * 2007-03-28 2010-08-03 Michael Robert Eastwood Chest protector in sports medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131315A2 (fr) * 1983-05-13 1985-01-16 ISTITUTO DE ANGELI S.p.A. Préparations nasales contenant des sels d'ammonium quaternaires anticholinergiques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PUTCHA LAKSHIMI ET AL: "Bioavailability of intranasal scopolamine in normal subjects.", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 85, no. 8, 1996, pages 899 - 902, XP002171369, ISSN: 0022-3549 *
See also references of WO9912544A1 *

Also Published As

Publication number Publication date
CA2303132C (fr) 2002-07-09
AU742878B2 (en) 2002-01-17
JP2002516815A (ja) 2002-06-11
AU9385098A (en) 1999-03-29
EP1027049A1 (fr) 2000-08-16
CA2303132A1 (fr) 1999-03-18
WO1999012544A1 (fr) 1999-03-18

Similar Documents

Publication Publication Date Title
DE69925266D1 (de) Verfahren und gerät zur behandlung von herzarhythmie
DE69807538D1 (de) Vorrichtung und Verfahren zur Behandlung von Gewebe
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
ATE230606T1 (de) Verfahren zur vorbeugung und behandlung von allergien
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69824312D1 (de) Verfahren und gerät zur beendigung von tachyarrhythmien
DE69839261D1 (de) Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
DE69841399D1 (de) Vorrichtung und Verfahren zur Trocknungsbehandlung
DE69829625D1 (de) Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
DE69624116D1 (de) Verfahren zur behandlung von allergischem asthma
DE69730097D1 (de) Verfahren und Vorrichtung zur Behandlung von Wafers
ATE230617T1 (de) Verfahren und methode zur behandlung von abfällen
ATE260083T1 (de) Verfahren zur behandlung der hautpigmentierung
DE69918306T2 (de) Verfahren und vorrichtung zur behandlung von arrythmien
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
DE69519107D1 (de) Verfahren und produkt zur wasserentkeimung
DE59812855D1 (de) Verfahren und vorrichtung zur behandlung von frischfleisch
DE69626311D1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69702997D1 (de) Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE59803932D1 (de) Verfahren zur reinigung und desinfektion von medizinischen instrumenten
DE69715922D1 (de) Verfahren und einrichtung zur behandlung von tabak
DE69729039T2 (de) Verfahren und vorrichtung zur behandlung von flaschen
DE60010750D1 (de) Verfahren und einrichtung zur behandlung von textilwaren
DE69805156D1 (de) Verfahren und Vorrichtung zur Behandlung von Musterplatten
DE69900339D1 (de) Mittel und Verfahren zur Behandlung von Kunstfasern

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000329

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010724

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020103

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NASTECH PHARMACEUTICAL COMPANY, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20051102